Latitude Group launches $100M capital notes offer
Latitude Group (ASX:LFS) launched an offer for Capital Notes 2, aiming to raise approximately $100 million to strengthen its capital structure.

Jon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.
Latitude Group (ASX:LFS) launched an offer for Capital Notes 2, aiming to raise approximately $100 million to strengthen its capital structure.
Delaware lawmakers introduced two new bills aimed at regulating stablecoin issuers and digital asset firms within the state.
Sanara MedTech (NASDAQ:SMTI) today announced its financial results for the fourth quarter and full year ended December 31, 2025, marking the first time the company has surpassed the $100 million annual revenue threshold.
Ocugen (NASDAQ:OCGN) today announced positive 12-month results from its Phase 2 ArMaDa clinical trial evaluating OCU410 (AAV-hRORA), a modifier gene therapy for the treatment of Geographic Atrophy (GA) secondary to dry Age-Related Macular Degeneration (dAMD).
Karyopharm Therapeutics (NASDAQ:KPTI) today announced topline results from its global Phase 3 SENTRY clinical trial (n=353) evaluating the XPO1 inhibitor selinexor in combination with ruxolitinib (Jakafi®) for the frontline treatment of patients with myelofibrosis.
Radiopharm Theranostics (NASDAQ:RADX) today released a highly encouraging second interim data update from its ongoing U.S. Phase 2b clinical trial evaluating RAD 101, a novel FASN-targeting small-molecule imaging agent.
Smithfield Foods (NASDAQ:SFD) today reported record financial results for fiscal year 2025, ended December 28, 2025, marking a period of significant operational recovery and strategic pivot.
Regeneron Pharmaceuticals (NASDAQ:REGN) and Sanofi today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Dupixent (dupilumab) for the treatment of adults with moderate-to-severe bullous pemphigoid (BP) whose disease is not adequately controlled by existing therapies.
Balancer Labs is shutting down after mounting financial pressure and a $116 million exploit, with plans to transition the protocol to community-led management.
Playnance has launched a new decentralised social gaming protocol powered by GCOIN, positioning it as a community-driven alternative to traditional platform-based gaming models.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy